Galderma’s gel-type facial flushing treatment about to be launched in Korea
A gel-type facial blushing treatment is expected to be commercialized in the domestic market.
According to the industry concerned on the 29th, Galderma has acquired domestic approval of ‘Mirvaso,’ a self-developed gel-type ‘brimonidine’ drug. Its official launching is expected in the first half ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
